tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

Hutchmed announces new, updated data from sovleplenib ESLIM-01 trial
The FlyHutchmed announces new, updated data from sovleplenib ESLIM-01 trial
4d ago
HCM
HUTCHMED to Present Promising Clinical Data in 2024
PremiumCompany Announcements
HUTCHMED to Present Promising Clinical Data in 2024
5d ago
Hutchmed to receive $20M milestone payment from Takeda for Fruzaqla sales
PremiumThe Fly
Hutchmed to receive $20M milestone payment from Takeda for Fruzaqla sales
10d ago
HCM
TAK
HUTCHMED Receives Milestone Payment from Takeda
PremiumCompany Announcements
HUTCHMED Receives Milestone Payment from Takeda
10d ago
HUTCHMED Announces Share Capital Details and Focus
PremiumCompany Announcements
HUTCHMED Announces Share Capital Details and Focus
10d ago
HUTCHMED Aligns Leadership with Share Awards
PremiumCompany AnnouncementsHUTCHMED Aligns Leadership with Share Awards
20d ago
Hutchmed announces results from SAVANNAH trial
Premium
The Fly
Hutchmed announces results from SAVANNAH trial
25d ago
AZN
HCM
HUTCHMED Unveils Promising Lung Cancer Trial Results
Premium
Company Announcements
HUTCHMED Unveils Promising Lung Cancer Trial Results
26d ago
Hutchmed, Takeda receive Japan MHLW approval to manufacture and market Fruzaqla
PremiumThe Fly
Hutchmed, Takeda receive Japan MHLW approval to manufacture and market Fruzaqla
2M ago
HCM
HUTCHMED’s Cancer Drug Approved in Japan
PremiumCompany Announcements
HUTCHMED’s Cancer Drug Approved in Japan
2M ago
HUTCHMED to Unveil New Cancer Study Insights
PremiumCompany Announcements
HUTCHMED to Unveil New Cancer Study Insights
2M ago
Hutchmed withdraws NDA in China for fruquintinib in combination with paclitaxel
PremiumThe Fly
Hutchmed withdraws NDA in China for fruquintinib in combination with paclitaxel
2M ago
HCM
HUTCHMED Updates Share Capital and Voting Rights
PremiumCompany AnnouncementsHUTCHMED Updates Share Capital and Voting Rights
2M ago
HUTCHMED Reassesses Gastric Cancer Drug Pathway
Premium
Company Announcements
HUTCHMED Reassesses Gastric Cancer Drug Pathway
2M ago
HUTCHMED Reports Major Shareholding Change
Premium
Company Announcements
HUTCHMED Reports Major Shareholding Change
3M ago
HUTCHMED Hosts ITP Treatment Webcast and Progresses Drug Trial
PremiumCompany Announcements
HUTCHMED Hosts ITP Treatment Webcast and Progresses Drug Trial
3M ago
HUTCHMED Incentivizes Talent with New Share Options
PremiumCompany Announcements
HUTCHMED Incentivizes Talent with New Share Options
3M ago
HUTCHMED Announces Board of Directors Structure
PremiumCompany Announcements
HUTCHMED Announces Board of Directors Structure
3M ago
HUTCHMED Reports Strong 2024 Interim Financial Growth
PremiumCompany Announcements
HUTCHMED Reports Strong 2024 Interim Financial Growth
3M ago
Hutchmed reiterates 2024 guidance for Oncology/Immunology revenue $300M-$400M
PremiumThe FlyHutchmed reiterates 2024 guidance for Oncology/Immunology revenue $300M-$400M
3M ago
HCM
Hutchmed reports 1H revenue $305.7M vs. $532.9M last year
Premium
The Fly
Hutchmed reports 1H revenue $305.7M vs. $532.9M last year
3M ago
HCM
HUTCHMED’s Drug Tazemetostat Nears China Market
Premium
Company Announcements
HUTCHMED’s Drug Tazemetostat Nears China Market
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >